|
1）KDIGO Clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl. 2013; 3: 259-305
|
|
|
|
|
2）LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005; 352: 1425-35
|
|
|
|
|
3）Moroi M, Tamaki N, Nishimura M, et al. Association between abnormal myocardial fatty acid metabolism and cardiac-derived death among patients undergoing hemodialysis: results from a cohort study in Japan. Am J Kidney Dis. 2013; 61: 466-75
|
|
|
|
|
|
4）Chan KE, Lazarus JM, Thadhani R, et al. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol. 2009; 20: 2223-33
|
|
|
|
|
|
5）Winkelmayer WC, Liu J, Setoguchi S, et al. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011; 6: 2662-8
|
|
|
|
|
|
6）Thet Z, Vilayur E. Atrial fibrillation and warfarin use in haemodialysis patients: an individualized holistic approach is important in stroke prevention. Nephrology (Carlton). 2013; 18: 331-9
|
|
|
|
|
|
7）Nakatani T, Naganuma T, Uchida J, et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2003; 23: 86-90
|
|
|
|
|
|
8）Sato M, Ogawa T, Sugimoto H, et al. Relation of carotid intima-media thickness and silent cerebral infarction to cardiovascular events and all-cause mortality in chronic hemodialysis patients. Intern Med. 2012; 51: 2111-7
|
|
|
|
|
9）Kobayashi S, Ikeda T, Moriya H, et al. Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis. 2004; 44: 35-41
|
|
|
|
|
|
10）Shima H, Ishimura E, Naganuma T, et al. Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities. Kidney Blood Press Res. 2011; 34: 430-8
|
|
|
|
|
|
11）Yokoyama S, Hirano H, Uomizu K, et al. High incidence of microbleeds in hemodialysis patients detected by T2*-weighted gradient-echo magnetic resonance imaging. Neurol Med Chir (Tokyo). 2005; 45: 556-60; discussion 560
|
|
|
|
|
|
12）Naganuma T, Takemoto Y, Yamasaki T, et al. Factors associated with silent cerebral microbleeds in hemodialysis patients. Clin Nephrol. 2011; 75: 346-55
|
|
|
|
|
|
13）Shima H, Ishimura E, Naganuma T, et al. Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant. 2010; 25: 1554-9
|
|
|
|
|
|
14）Kuriyama N, Mizuno T, Ohshima Y, et al. Intracranial deep white matter lesions (DWLs) are associated with chronic kidney disease (CKD) and cognitive impairment: a 5-year follow-up magnetic resonance imaging (MRI) study. Arch Gerontol Geriatr. 2013; 56: 55-60
|
|
|
|
|
|
15）Shaffi K, Tighiouart H, Scott T, et al. Low 25-hydroxyvitamin d levels and cognitive impairment in hemodialysis patients. Clin J Am Soc Nephrol. 2013; 8: 979-86
|
|
|
|
|